Evidence map›Paper›PMID 33131500›Full record

ArticleBMC public health2020

The Haiti cardiovascular disease cohort: study protocol for a population-based longitudinal cohort.

Jean Lookens, Olga Tymejczyk, Vanessa Rouzier, Caleigh Smith, Fabyola Preval, Inddy Joseph, Raynold Jean Baptiste, Joscar Victor, Patrice Severe, Sandra Apollon and 16 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03892265 (A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti), which is not on this map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03892265 active not recruitingnot on this map

A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti

TypeobservationalSponsorWeill Medical College of Cornell UniversityRan2019 to 2028Enrolled3,005ConditionsHypertension, Diabetes, Obesity, Kidney DiseasesArmsObservational Study
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Observational
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 5 institutions in 2 countries.

Jean LookensHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Olga TymejczykCUNY Institute for Implementation Science in Population Health, New York, NY, USA.
Vanessa RouzierHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Caleigh SmithCenter for Global Health, Weill Cornell Medicine, New York, NY, USA.
Fabyola PrevalHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Inddy JosephHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Raynold Jean BaptisteHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Joscar VictorHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Patrice SevereHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Sandra ApollonHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Emelyne DumontHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Guyrlaine ForestalHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Stephano St PreuxHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Vanessa RiveraHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Grace SeoCUNY Institute for Implementation Science in Population Health, New York, NY, USA.
Benedict CharlesHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Wilson AristeHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Justin KingeryCenter for Global Health, Weill Cornell Medicine, New York, NY, USA.
Jessy DevieuxDepartment of Health Promotion and Disease Prevention, Stempel College of Public Health and Social Work, Miami, FL, USA.
Serena KoenigDivision of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA.
Denis NashCUNY Institute for Implementation Science in Population Health, New York, NY, USA.
Daniel FitzgeraldCenter for Global Health, Weill Cornell Medicine, New York, NY, USA.
Monika SaffordDivision of General Internal Medicine, Weill Cornell Medicine, New York, NY, USA.
Marie Marcelle DeschampsHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Jean PapeHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Margaret McNairyCenter for Global Health, Weill Cornell Medicine, New York, NY, USA. mam9365@med.cornell.edu.
Gheskio Centers · HTCornell University · USWeill Cornell Medicine · USBrigham and Women's Hospital · USCenter for Global Health · US

Funding

Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
GHESKIO HIV Clinical Trial UnitUM1AI069421 · NIAID · GHESKIO CENTER · PI JEAN WILLIAM PAPE · 2012 to 2026
$23.6M
Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep DisordersR01HL143788 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Margaret Leighton McNairy · 2018 to 2026
$8.9M
Cardiovascular Disease Research Training Program in HaitiD43TW011972 · FIC · WEILL MEDICAL COLL OF CORNELL UNIV · PI Margaret Leighton McNairy, JEAN WILLIAM PAPE · 2021 to 2026
$1.4M
Global Health Research and Training in Cardiovascular DiseaseK24HL163393 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Margaret Leighton McNairy · 2022 to 2026
$604k
FIC NIH HHS D43 TW011972NCATS NIH HHS UL1 TR002384NHLBI NIH HHS K24 HL163393NHLBI NIH HHS R01 HL143788NHLBI NIH HHS R01 HL143788-01NIAID NIH HHS UM1 AI069421
6 · The paper itself

Abstract

backgroundCardiovascular disease (CVD) is the leading cause of mortality among Haitians, having surpassed HIV in the last decade. Understanding the natural history of CVD in Haitians, including the age of onset, prevalence, incidence, and role of major risk factors and social determinants, is urgently needed to develop prevention and treatment interventions. Aim 1: Establish a population-based cohort of 3000 adults from Port-au-Prince and assess the prevalence of CVD risk factors and diseases and their association with social and environmental determinants. Aim 2: Determine the incidence of CVD risk factors and CVD during 2-3.5 years of follow-up and their association with social and environmental determinants.

methodsThe Haiti CVD Cohort is a longitudinal observational study of 3000 adults > 18 years in Port-au-Prince (PAP), Haiti. The study population is recruited using multistage random sampling from census blocks. Adults receive blood pressure (BP) measurements in the community and those with elevated BP are referred to the Groupe Haitien d'Etude Sarcome de Kaposi et des Infections Opportunistes Clinic for care. After informed consent, participants undergo a clinical exam with medical history. BP, electrocardiogram, echocardiogram, a study questionnaire on health behaviors, and laboratory specimens. Every 6 months, BP is remeasured. At 12 and 24 months, clinical exams and questionnaires are repeated. Labs are repeated at 24 months. Adjudicated study outcomes include the prevalence and incidence of CVD risk factors (hypertension, diabetes, obesity, dyslipidemia, kidney disease, inflammation, poor diet, smoking, and physical inactivity) and events (myocardial infarction, heart failure, stroke, and CVD mortality). We also measure social determinants including poverty. Depression, stress, social isolation, food insecurity, and lead exposure. Blood, urine, and stool samples are biobanked at study enrollment. DISCUSSION: The Haiti CVD Cohort is the largest population-based cohort study evaluating CVD risk factors and CVD among adults in urban Haiti with the goal of understanding the drivers of the CVD epidemic in Haiti. Study outcomes are comparable with existing international cohorts, and the biobank will provide important data for future research. Our goal is to translate findings from this study into pragmatic prevention and treatment interventions to fight the CVD epidemic in Haiti.

Indexed as

Cardiovascular DiseasesHIV InfectionsAdultCohort StudiesHaitiHumansObservational Studies as TopicRisk FactorsCardiovascular medicineEpidemiologyHypertensionPublic health

Identifiers

PMID33131500
PMCPMC7603639
OpenAlexW3094695906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.